Related Experiment Video
Updated: Jul 7, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
Melatonin Regulates Osteoblast Differentiation through the m6A Reader hnRNPA2B1 under Simulated Microgravity
Quan Sun1, Liqun Xu1, Zebing Hu1
1The Key Laboratory of Aerospace Medicine, Ministry of Education, Air Force Medical University, Xi'an 710032, China.
Current Issues in Molecular Biology
|September 27, 2024
Summary
Melatonin and N6-methyladenosine (m6A) modification influence bone health. This study reveals melatonin promotes bone formation by upregulating hnRNPA2B1, a key m6A reader, offering a new strategy against microgravity-induced bone loss.
Area of Science:
- Bone Biology
- Space Medicine
- Epigenetics
Background:
- Melatonin and N6-methyladenosine (m6A) modification impact bone cell differentiation and formation.
- Melatonin regulates biological processes, potentially via m6A.
- Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) is an m6A reader.
Purpose of the Study:
- To investigate the role of the melatonin/hnRNPA2B1 axis in osteoblast differentiation under simulated microgravity.
- To explore potential therapeutic strategies for microgravity-induced bone loss.
Main Methods:
- Utilized hindlimb unloading model for simulated microgravity in vivo.
- Employed 2D clinorotation for simulating microgravity in vitro.
- Assessed hnRNPA2B1 expression and its effect on osteoblast differentiation.
Main Results:
- hnRNPA2B1 expression was downregulated in simulated microgravity.
- hnRNPA2B1 promotes osteoblast differentiation; its overexpression counteracted microgravity's suppressive effects.
- Melatonin increased hnRNPA2B1 expression under simulated microgravity.
- Melatonin's promotion of osteoblast differentiation was partly dependent on hnRNPA2B1.
Conclusions:
- The melatonin/hnRNPA2B1 axis plays a crucial role in osteoblast differentiation under simulated microgravity.
- Targeting this axis presents a potential protective strategy against microgravity-induced bone loss and osteoporosis.
